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Abstract
Background: It is known that retinoid receptor function is attenuated during T cell activation, a phenomenon that
involves actin remodeling, suggesting that actin modification may play a role in such inhibition. Here we have
investigated the role of actin dynamics and the effect of actin cytoskeleton modifying agents on retinoid receptor-
mediated transactivation.
Results: Agents that disturb the F-actin assembly or disassembly attenuated receptor-mediated transcription
indicating that actin cytoskeletal homeostasis is important for retinoid receptor function. Overexpression or siRNA-
induced knockdown of cofilin-1 (CFL1), a key regulator of F-actin assembly, induced the loss of receptor function.
In addition, expression of either constitutively active or inactive/dominant-negative mutants of CFL1or CFL1 kinase
LIMK1 induced loss of receptor function suggesting a critical role of the LIMK1-mediated CFL1 pathway in
receptor-dependent transcription. Further evidence of the role of LMK1/CFL1-mediated actin dynamics, was
provided by studying the effect of Nef, an actin modifying HIV-1 protein, on receptor function. Expression of Nef
induced phosphorylation of CFL1 at serine 3 and LIMK1 at threonine 508, inhibited retinoid-receptor mediated
reporter activity, and the expression of a number of genes that contain retinoid receptor binding sites in their
promoters. The results suggest that the Nef-mediated inhibition of receptor function encompasses deregulation of
actin filament dynamics by LIMK1 activation and phosphorylation of CFL1.
Conclusion: We have identified a critical role of LIMK1-mediated CFL1 pathway and actin dynamics in modulating
retinoid receptor mediated function and shown that LIMK1-mediated phosphocycling of CFL1 plays a crucial role
in maintaining actin homeostasis and receptor activity. We suggest that T cell activation-induced repression of
nuclear receptor-dependent transactivation is in part through the modification of actin dynamics.
Background
Nuclear retinoid receptors are retinoid-induced transcrip-
tion factors that mediate a wide array of cellular functions
including growth, differentiation, and cell death. While the
role of these receptors in immune function has been
recognized early, it is only recently that retinoids have
been identified to play a crucial role in T lymphocyte phy-
siology like regulatory T cell development and suppression
of inflammatory Th17 cells [1-4]. Our understanding of
the mechanism of retinoid receptor function in T cells is
however, not well defined. Our previous studies have pro-
vided some insights in the functioning of these receptors
and have identified the relevance of epigenetic mechan-
isms in modulating their function during T cell signaling
[5-9].
A major signaling event during T cell activation is the
organization of the actin cytoskeleton and immunological
synapse (IS) formation. These events are crucial for down-
stream signaling that culminates in effector functions and
cytokine production [10,11]. Recent studies have identified
CFL1, an actin binding protein, as an essential component
of T cell activation that is crucial for IS formation and
T cell activation. Most of the CFL1 in naive T cells is
found in the inactive phosphorylated form that following
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form of CFL1 binds actin and regulates F-actin dynamics.
Serine/threonine kinase LIMK1 and phosphatases PP1,
PP2A, slingshot 1L (SSH1L), and chronophin (CIN) are
known to regulate the phosphorylated state of CFL1
[14-16].
HIV-1 gains entry into T cells by the interaction of
viral proteins with receptors and co-receptors. This inter-
action leads to the perturbation in actin dynamics and
viral replication. Recent studies have identified CFL1 as a
central player in regulating the modification of the actin
cytoskeleton by HIV-1 proteins gp120 and Nef [17-21].
Nef is known to interact with actin and modify actin
cytoskeletal dynamics and the T cell receptor initiated
signaling cascade. Nef has been also shown to inhibit IS
formation and cell spreading by modifying actin function
[22,23]. There is ample evidence that actin plays a func-
tional role in nuclear transcription and disturbances in
actin dynamics affect transcriptional outcome [24-32].
We have reported earlier that T cell activation silenced
transcription driven by nuclear retinoid receptors and
induced silencing mediator of retinoic acid and thyroid
hormone receptors (SMRT)-receptor interaction (6). We
also identified a dynamic balance between JNK and ERK
pathways in modulating retinoid-receptor function (8).
The mechanism by which T cell activation induces loss
of transcription is still not completely understood. In this
report we have focused our studies to investigate the role
of actin cytoskeleton homeostasis and dynamics in
nuclear retinoid receptor-mediated transactivation. Our
results indicate a critical role of LIMK1-mediated CFL1
pathway and actin dynamics in retinoid receptor func-
tion. The data suggest that changes in the actin cytoske-
letal dynamics may indeed contribute to the loss of
nuclear retinoid receptor function following T cell
activation.
Results
F-actin-modifying chemicals attenuate retinoid receptor-
mediated transcription
One of the outcomes of T cell activation is remodeling of
the actin cytoskeleton crucial for the formation of IS. We
have previously shown that T cell activation inhibits
nuclear retinoid receptor mediated function [6,8] raising
the possibility that actin modification may have a role in
such inhibition. To confirm the role of actin dynamics in
transcriptional activation we studied the effect of actin
modifying agents on receptor function. Jurkat cells were
transfected with RXRE reporter plasmid and after incuba-
tion for 24 h treated for 16 h with 9-cis retinoic acid or
vehicle in the presence of latrunculin A (50 nM), swinho-
lide A (2.5 nM); chemicals that prevent F-actin formation,
or jasplakinolide (50 nM) a compound that induces
F-actin formation and stabilization. All these inhibitors
were found to attenuate ligand independent and ligand-
dependent transcription (Figure 1A). We used SP1-Luc
reporter plasmid as a control as the transcription driven
by this promoter was not significantly affected by these
agents (Figure 1B). These results demonstrate that F-actin
dynamics and assembly are critical for retinoid receptor-
mediated transcription.
CFL1 plays a critical role in regulating retinoid receptor
function via establishing dynamic balance between
F-actin stabilization and disassembly
CFL1 is known to play a central role in maintaining actin
cytoskeletal dynamics by severing F-actin and allowing
for re-organization and formation of new filaments
[14-16]. Since our data suggested that retinoid receptor
function is sensitive to changes in F-actin organization,
we explored the possibility that CFL1 may play an impor-
tant role in retinoid receptor activation by knocking
down CFL1 protein and testing for retinoid receptor-
mediated activation. Jurkat cells were transfected with
reporter plasmid in the presence or absence of a control
siRNA or CFL1 specific siRNA. Western blot analysis
showed a nearly 75% knockdown of CFL1 protein in cells
transfected with CFL1 specific siRNA as compared with
cells transfected in the absence of siRNA or control
siRNA (Figure 2A). When the lysates were tested for luci-
ferase activity there was significant reduction in activity
in cells transfected with CFL1-specific siRNA as com-
pared with cells transfected in the absence of siRNA or
the presence of control siRNA (Figure 2B). These results
indicate that CFL1 is essential for retinoid receptor-
mediated transcription. To further study the role of CFL1
in retinoid receptor activation we overexpressed CFL1 in
Jurkat cells and studied its effect on transcription. The
results obtained (Figure 2C and 2D) show that overex-
pression of CFL1/WT reduced transcriptional activation
in a dose dependent manner. Taken together, knockdown
and overexpression data indicate that retinoid receptor-
mediated transcription is sensitive to the changes in the
levels of CFL1 expression and any decrease or increase in
the levels of CFL1 results in the loss of transcriptional
activity.
F-actin severing activity of CFL1 is regulated by phos-
phorylation of the serine residue at amino acid position
3. Whereas non-phosphorylated CFL1 binds and severs
F-actin, phosphorylated CFL1 is inactive and its accumu-
lation leads to the increase in F-actin content [14-16].
Expression of the S3A mutant of CFL1 generates a pro-
tein that is not phosphorylatable and hence is constitu-
tively active. In contrast, the S3E mutant of CFL1 mimics
phosphorylated CFL1 and also functions as dominant-
negative protein [16]. To identify the role of S3 phos-
phorylation in CFL1-regulated retinoid receptor function,
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presence of CFL1/WT, CFL1/S3A, and CFL1/S3E plas-
mids. Surprisingly, expression of both mutants of CFL1
inhibited transcription in a dose dependent manner
(Figure 2C and 2D) similar to the inhibition by CFL1/
WT described above. The inhibition was more pro-
nounced with S3A and S3E mutants as compared to
CFL1/WT; the S3E mutant was most inhibitory of the
three. We used SP1-Luc reporter plasmid as a control
and studied the effect of CFL1/WT, CFL1/S3A, and
CFL1/S3E expression on its activity. The data (Figure 2E)
show that the SP1 activity was not affected by the expres-
sion of either WT or CFL1 mutants. To study the
changes in the F-actin levels after transfection with
CFL1/WT, CFL1/S3A, and CFL1/S3E plasmids, the cells
were stained with anti-V5 Tag antibodies followed by
treatment with F-actin stain. The cells were visualized
(Figure 2F) and the levels of F-actin quantified (Figure
2G) using immunofluorescent microscopy. The results
show that cells transfectedw i t hC F L 1 / W Ta n dC F L 1 /
S3A plasmids showed lower levels of F-actin as compared
to cells not expressing the plasmid with CFL1/S3A
expressing cells exhibiting lowest F-actin levels. In con-
trast cells transfected with CFL1/S3E plasmid showed
accumulation of F-actin and expressed significantly
higher levels of F-actin as compared to non-transfected
cells.
Together, these results show that while CFL1 is essential
for retinoid receptor function, when expressed at higher
levels both active and inactive forms inhibit transcription.
In other words, CFL1 regulates retinoid receptor depen-
dent transcriptional homeostasis by maintaining a dynamic
balance between F-actin stabilization and disassembly
mediated by the inactive phosphorylated and the active
non-phosphorylated forms of the protein.
CFL1 kinase LIMK1 regulates retinoid receptor mediated
activation
LIMK1 is a threonine/serine protein kinase, a member of
the LIM kinase (LIMK) family that is involved in the regu-
lation of actin polymerization and microtubule disassem-
bly. Although a number of proteins have been identified
that are known to interact with LIMK1, CFL1 is the only
known substrate for the enzyme. LIMK1 modulates actin
dynamics by phosphorylating and inactivating CFL1 lead-
ing to the accumulation of F-actin[14]. The role of LIMK1
in the nuclear retinoid receptor function is unknown.
Based on our observation that CFL1 plays a crucial role in
regulating retinoid receptor function, we next explored the
role of LIMK1 in retinoid receptor function. As shown
Figure 1 F-actin-modifying chemicals attenuate retinoid receptor-mediated transcription. Jurkat cells were transfected with 5.0 ug
TATADR1-Luc (A) or SP1-Luc plasmids (B). After 24 h, TATADR1-Luc transfected cells were treated for 16 h with 9-cis retinoic acid (1.0 uM) or
vehicle in the presence of DMSO, or actin inhibitors latrunculin A (50 nM), swinholide A (2.5 nM) or jasplakinolide (50 nM). After 24 h, Sp1-Luc
transfected cells were treated with DMSO or actin inhibitors for 16 h. Cells were harvested and luciferase activity measured as described in
Experimental Procedures.
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Jurkat cells inhibited retinoid receptor mediated transcrip-
tion in a dose dependent manner. A LIMK1 mutant
LIMK1/D460A is a kinase dead mutant that also functions
as a dominant-negative inhibitor of LIMK1[33]. Transfec-
tion of Jurkat cells with reporter plasmid in the presence
of LIMK1/D460A mutant plasmid also inhibited transcrip-
tion driven by retinoid receptors in a dose dependent
manner (Figure 3A, B). We used SP1-Luc reporter plasmid
as a control and studied the effect of LIMK1/WT, and
LIMK1/D460A expression on its activity. The data (Figure
3C) show that the SP1 activity was not significantly
affected by the expression of the WT or mutant LIMK1.
Together, these results suggest that the steady state levels
of LIMK1 are important for normal retinoid receptor
function. When overexpressed, LIMK1 functions as a
negative regulator of retinoid receptor-mediated transcrip-
tion. The inhibition of transcription exhibited by the
expression of inactive and dominant negative LIMK1/
D460A mutant provides further evidence for the impor-
tance of the steady state levels of the LIMK1 enzyme in
regulating normal receptor function. Because overexpres-
sion and inhibition of LIMK1 will induce hyperphosphory-
lation and dephosphorylation of CFL1, respectively, any
Figure 2 CFL1 regulates retinoid receptor function. A and B) Jurkat cells were transfected with 2.5 ug of TKRARE-Luc plasmid either in the
presence or absence of 2.5 uM control siRNA or CFL1-specific siRNA. Cells were harvested after 36 h and lysates subject to Western blotting
using antibodies to CFL1 and beta-actin (A) and luciferase activity measurement (B) as described in Experimental Procedures. C and D) Jurkat
cells were transfected with 5.0 ug TATADR1-Luc in the presence of 2.5 ug and 5.0 ug of indicated plasmids. Cells were harvested after 36 h and
luciferase activity measured as described in Experimental Procedures (C). Lysates were also subject o Western blotting using antibodies to anti-V5
tag (1:2,000) and beta-actin (1:10,000) (D). E) Jurkat cells were transfected with 5.0 ug of SP1-Luc plasmid in the presence of 5 ug of indicated
plasmids. Cells were harvested after 36 h and luciferase activity measured as described in Experimental Procedures. SP1-Luc activity obtained in
the presence of vector was normalized to 100%. F and G) Jurkat cells were transfected with CFL1/WT, CFL1/S3A, and CFL1/S3E plasmids and
stained with anti-V5 Tag antibodies followed by treatment with F-actin stain as per the instructions of the manufacturer. The cells were
visualized using immunofluorescent microscopy (F) and the densitometric mean intensity of F-actin from V5-CFL1 positive cells was quantified
and compared to non-V5-CFL1 expressing control cells (G) using AxioVision software from Zeiss Imager D1 fluorescent microscope. Bar, 2 um.
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transcription. Thus LIMK1-mediated CFL1 homeostasis is
crucial for receptor function. To investigate if the transfec-
tion of LIMK1/WT and LIMK1/D460A plasmids induce
changes in the F-actin levels, the transfected cells were
stained with anti-V5 Tag antibodies followed by staining
with F-actin stain. The cells were visualized (Figure 3D)
and the levels of F-actin quantified (Figure 3E) using
immunofluorescent microscopy. The results show that
cells transfected with LIMK1/WT plasmid showed signifi-
cant accumulation and higher levels of F-actin as com-
pared to cells not expressing the plasmid. In contrast, cells
transfected with LIMK1/D460A plasmid expressed lower
F-actin levels as compared to non-transfected cells. These
data are consistent with the ability of LIMK1/WT expres-
sion to induce phosphorylation and inactivation of CFL1
resulting in the accumulation of F-actin, whereas expres-
sion of LIMK1/D460A has the opposite effect of increas-
ing active CFL1 (by inhibiting phosphorylation) and
inducing loss of F-actin. Together, these data indicate that
LIMK1 functions as a critical regulator of retinoid receptor
transcription by regulating F-actin homeostasis.
Actin modifying HIV-1 Nef protein attenuates retinoid
receptor-mediated transcription
Recent studies have identified CFL1 as a central player in
regulating the modification of the actin cytoskeleton by
HIV-1 proteins gp120 and Nef [17-21]. Nef is known to
interact with actin and modify actin cytoskeletal dynamics
and the T cell receptor initiated signaling cascade. Nef also
has been shown to inhibit IS formation and cell spreading
by modifying actin function [22,23]. Nef functions by
Figure 3 LIMK1 regulates retinoid receptor function. A and B) Jurkat cells were transfected with 5.0 ug TATADR1-Luc in the presence of 2.5
ug and 5.0 ug of indicated plasmids. Cells were harvested after 36 h and luciferase activity measured as described in Experimental Procedures
(A). Lysates were also subject o Western blotting using antibodies to anti-V5 tag (1:2,000) and beta-actin (1:10,000) (B). C) Jurkat cells were
transfected with 5.0 ug of SP1-Luc plasmid in the presence of 5 ug of indicated plasmids. Cells were harvested after 36 h and luciferase activity
measured as described in Experimental Procedures. SP1-Luc activity obtained in the presence of vector was normalized to 100%. D and E) Jurkat
cells were transfected with LIMK1/WT, and CFL1/D460A plasmids and stained with anti-V5 Tag antibodies followed by treatment with F-actin
stain. The cells were visualized using immunofluorescent microscopy (D) and the densitometric mean intensity of F-actin from V5-LIMK1 positive
cells was quantified and compared to non-V5-LIMK1 expressing control cells (E) using AxioVision software from Zeiss Imager D1 fluorescent
microscope. Bar, 2 um.
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rafts through myristoylation. We first studied the effect of
wild-type (WT) and myristoylation (G2A) mutant of HIV-
1 Nef on F-actin assembly using immunofluorescence
microscopy. Jurkat cells were transfected with Nef/WT and
Nef/G2A plasmids and 36 h later stained with anti-Nef
antibody and F-actin specific fluorophore-labeled phalloi-
d i n .A ss h o w ni nF i g u r e4 Ae x p r e s s i o no fW Tb u tn o t
G2A mutant of Nef induced loss of characteristic F-actin
ring assembly in these cells. Next, we investigated the effect
of Nef on retinoid receptor mediated transcription. Jurkat
and PBT cells transfected with either RXRE or RARE con-
taining luciferase-based reporter plasmids in the presence
of Nef-expressing plasmid showed a significant loss
of reporter activity when compared to cells transfected
with a non-expressing Nef control plasmid (Figure 4B and
Figure 4C).
SP1-Luc reporter was used a control as Nef did not
have significant effect on the activity of this promoter
(Figure 4D). To study if the T cell activation signals
synergized with Nef in inhibiting transcription, cells were
transfected with Nef expressing plasmid in the presence
of antibodies to T cell receptors CD3 and CD28 or treat-
ment with PMA+PHA (Figure 4B and Figure 4C). The
data show that activation significantly enhanced Nef
induced loss of receptor activity. In order to identify the
Figure 4 HIV-1 Nef induces loss of F-actin assembly and inhibits retinoid receptor-mediated transcription.A )J u r k a tc e l l sw e r e
transfected for 36 h with 5.0 ug of Nef/WT or Nef/G2A plasmids using Fugene-HD. The cells were fixed, permeabilized, and blocked with BSA as
described in Experimental Procedures. Cells were incubated with anti-Nef anti-serum (1:500 in 5% BSA/PBS) for 1-2 h and labeled with FITC-
conjugated secondary antibody. Cells were stained for F-actin using Alexa Fluor 555 Phalloidin and mounted in Prolong Gold Antifade Reagent
with DAPI. Confocal images were obtained using an Olympus Fluoview 1000-inverted microscope. Each figure is a quadron for DAPI, Nef, F-actin,
and merged images. F-actin stained Nef expressing cells are indicated by arrows. Bar, 2.5 um. B-E) Jurkat (B, E) or PBT (C) cells were transfected
with 5.0 ug TATADR1-Luc or TKCRBPII-Luc plasmids respectively in the presence of 2.5 ug of indicated plasmids. After 16 h, cells were treated as
indicated and luciferase activity measured 24 h later as described in Materials and Methods. D) Jurkat cells were transfected with 2.5 ug of SP1-
Luc in the presence of indicated plasmids and luciferase activity measured 36 h later. F) Jurkat cells were transfected with 5.0 ug TATADR1-Luc
in the presence of 2.5 ug of indicated plasmids. After 16 h, cells were treated with indicated compounds and luciferase activity measured 24 h
later as described in Experimental Procedures.
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tested in reporter assays. The results show (Figure 4E)
that loss of myristoylation significantly reduced the abil-
ity of Nef to induce inhibition. Next, we studied the effect
of F-actin-modifying chemicals on transcriptional activa-
tion in the presence of Nef to see if the latter cooperated
with the chemicals in inhibiting transcription. Jurkat cells
were transfected with reporter plasmid either in the pre-
sence of Nef/WT or Nef/Stop plasmids for 24 h followed
by treatment with chemicals. The results (Figure 4F)
demonstrate that Nef is signifi c a n t l ym o r ei n h i b i t o r yi n
the presence of actin-modifying chemicals. Nef cooperat-
ing with actin-modifying chemicals points to the modula-
tion of F-actin assembly as a possible mechanism for Nef-
induced inhibition of transcriptional activation.
Nef inhibits the expression of cellular genes containing
retinoid receptor binding sites in their promoters
Nef was also found to inhibit RXRE or RARE containing
luciferase-based reporter activity in HEK-293 cells (data
not shown) indicating that Nef inhibition of retinoid recep-
tor function is not limited to T cells alone. To confirm the
data obtained by the reporter assays and identify retinoid
receptor-dependent cellular genes that are inhibited by Nef
expression, we transfected 293 cells with Nef/Stop and
Nef/WT plasmids and the effect on cellular transcriptome
was analyzed by gene array. The data identified that Nef
inhibited the expression of five genes that contain retinoid
receptor binding sites in their promoters (Table 1). IFIT1,
CEBPB, and CRABP2 are known retinoic acid inducible
genes [34-36]whereas RBM8A and ACOT2 were found to
contain DR2 (RARE) and DR1 (RXRE) consensus sequence
elements, respectively, within their promoter regions
upstream of the transcription start site. Real-Time RT-PCR
was used to confirm the inhibition of gene expression.
Nef inhibition of retinoid receptor function is mediated
by LIMK1-dependent CFL1 pathway
LIMK1 functions with CFL1 to control the assembly of
actin. To understand the mechanism of Nef-induced
modulation of actin-dynamics and nuclear receptor-
mediated function, we next investigated the possibility
that overexpression of Nef could regulate CFL1 activity
by modifying the level of CFL1 phosphorylation. These
studies were performed in 293 cells that also exhibited
F-actin changes after transfection with Nef (data not
shown). Cells were transfected with plasmids expressing
Nef/WT or Nef/G2A mutant. Western blot analysis of
the extracts collected after 36 hr of transfection showed
that cells transfected with Nef/WT expressed signifi-
cantly higher levels of phosphorylated CFL1 as com-
pared to cells transfected with control or Nef/G2A
plasmids (Figure 5A). The levels of total CFL1 remained
unchanged. These data show that Nef induces CFL1
phosphorylation and myristoylation of Nef protein is
crucial for this activity of Nef.
We next explored the effect of Nef on CFL1 phosphory-
lation using immunofluorescence microscopy. 293 cells
were transfected with either Flag-tagged Nef/WT or Flag-
tagged Nef/G2A plasmids. After 36 h cells were stained
with anti-Flag and anti-phospho CFL1 antibodies. Micro-
scopic study revealed that Nef expression induced morpho-
logical changes in 293 cells. Although still attached to the
surface, Nef-expressing cells appeared more rounded in
shape than cells not expressing Nef or cells that expressed
the G2A mutant of Nef (Figure 5B). In addition, Nef-
expressing and rounded cells showed significantly higher
levels of phospho-CFL1 staining as compared to cells not
expressing Nef and cells expressing the G2A mutant pro-
tein (Figure 5C and 5D). These results confirm Western
blotting results that expression of the myristoylated form
of Nef induces CFL1 phosphorylation.
Based on our findings in this study that overexpression
of the CFL1 kinase LIMK1 inhibits retinoid receptor-
mediated transactivation and Nef induces phosphoryla-
tion of CFL1, it was logical to hypothesize that Nef
attenuates retinoid receptor mediated activation by indu-
cing the activation of LIMK1 which in turn increases
CFL1 phosphorylation. To test the hypothesis that Nef
induces activation of LIMK1, we transfected 293 cells
Table 1 Nef-induced inhibition of retinoid receptor-mediated gene expression
Name Accession # RXRE/RARE site in the promoter Fold Change Reference
Gene Array Real-Time-RT-PCR
IFIT1 NM_001548 Retinoic acid-inducibility known -2.12 -8.30 [34]
RBM8A BC071577 AGGTCAGGAGTTCA -1.82 -1.61 -
ACOT2 NM_006821 AGCTCAGAGGTCA -1.75 -1.32 -
CEBPB NM_005194 Retinoic acid-inducibility known -1.50 -1.60 [35]
CRABP2 NM_001878 Retinoic acid-inducibility known -1.32 -1.74 [36]
293 cells were transfected with Nef/Stop and Nef/WT plasmids for 36 h. Total RNA was isolated and processed for gene array as described in Experimental
Procedures. Five genes whose expression was significantly inhibited by Nef were identified to be either known retinoic acid-inducible genes or contained RAR/
RXR binding sites in their promoters. IFIT1, CEBPB, and CRABP2 were found to be known retinoic acid-inducible genes whereas. RBM8A and ACOT2 were found
to contain putative RARE (DR2) and RXRE (DR1) sites respectively in their promoter regions upstream of the transcription start site. The inhibition of gene
expression was validated by Real-Time RT-PCR.
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plasmids for 36 h and studied LIMK1 phosphorylation at
Thr508. Phosphorylation at Thr508 is known to activate
the LIMK1 enzyme [33]. Immunofluorescence analysis of
the transfected cells using antibodies specific to phos-
pho-LIMK1 (antibodies to phospho-peptide correspond-
ing to residues surrounding Thr508 of LIMK1) revealed
that Nef expressing cells, that also showed the “rounding
off” phenotype, exhibited significantly higher levels of
phospho-LIMK1 staining as compared to cells not
expressing Nef (Figure 6). In contrast, cells expressing
the G2A mutant protein that did not show the “rounding
off” phenotype, exhibited phospho-LIMK1 levels similar
to the cells not expressing the Nef protein. These results
confirm the hypothesis that Nef induces the activation
(phosphorylation) of LIMK1. In addition, the data also
reveal that myristoylation of Nef is necessary to induce
the “rounding off” phenotype and activation of LIMK.
Figure 5 Nef induces CFL1 phosphorylation. A) 293 cells were transfected with Nef/Stop, Nef/WT or Nef/G2A plasmids for 36 h. Cell lysates
were then subject to Western blotting using antibodies to Nef (1:2,000), total CFL1 (1:1,000), phospho-serine-3-CFL1 (1:2,000), and GAPDH
(1:5,000). The intensity of the phospho-serine-3-CFL1 bands was quantified and normalized to Nef/Stop that was assigned a value of 1.0. B and
C) 293 cells transfected with either Flag-tagged Nef/WT or Flag-tagged Nef/G2A plasmids were fixed, permeabilized, and blocked with BSA (as
described in Experimental Procedures), incubated with anti-Flag (B) or anti-Flag and anti-phospho-serine-3-CFL1 antibodies (C) (1:500 in 5% BSA/
PBS) for 2 h, and stained with FITC-conjugated (B) or FITC-conjugated and Alex-Fluor-555 labeled secondary antibodies (C). The cells were
mounted in Prolong Gold Antifade Reagent before immunofluorescence microscopy. Fig 5B also shows the phase contrast image of 293 cells
expressing Flag-tagged Nef/WT exhibiting “rounding off” phenotype unlike cells expressing Flag-tagged Nef/G2A. The arrows in Fig. 5B identify
non-Nef expressing cells. The panels in Fig 5C are for Nef, p-CFL1, and merged images. The arrows in Fig. 5C identify Nef expressing cells. Bar, 5
um. D) The densitometric mean intensity of p-CFL1 stained cells was quantified from Nef/WT and Nef/G2A transfected cells and compared to
non-Nef expressing cells.
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The actin cytoskeleton undergoes major changes during T
lymphocyte migration, antigen-driven activation, apopto-
sis, and infection with retroviruses [10-14,17,19-21]. These
events result in the activation of various signaling compo-
nents that are assembled and brought into the close proxi-
mity by the actin cytoskeleton. Actin cytoskeletal
homeostasis also regulates gene expression by modulating
chromatin remodeling, mRNA processing, and nuclear
export [24-30,32]. Thus actin pathways regulate cellular
functions by the dual processes of modulating signaling
and also directly participating in nuclear transcription. It is
known that retinoid receptor function is attenuated during
T cell activation [6,8], a phenomenon that involves actin
remodeling, suggesting that actin modification may play a
role in such inhibition. In this study we set out to investi-
gate the role of actin cytoskeleton homeostasis and
dynamics in retinoid receptor-mediated transcription.
Latrunculin A, swinholide A, compounds that prevent
F-actin formation, or jasplakinolide, a chemical that
induces F-actin formation and stabilization, were all found
to attenuate transcription to various levels. These results
point out the importance of actin homeostasis in retinoid
receptor-mediated activation and indicate that any distur-
bances in actin dynamics and the F-actin homeostasis
attenuate retinoid receptor-dependent transcription.
Figure 6 Nef induces LIMK1 activation. 293 cells were transfected with either Flag-tagged Nef/WT (A) or Flag-tagged Nef/G2A (B) plasmids.
After 36 h cells were fixed, permeabilized, and blocked with BSA as described in Experimental Procedures. Cells were incubated with anti-Flag
tag (1:500 in 5% BSA/PBS) and phospho-specific LIMK1 (1:250 in 5% BSA/PBS) antibodies for 2 h and labeled with FITC-conjugated (Flag) and
Alex-Fluor-555 labeled (phospho-CFL1) secondary antibodies. The cells were mounted in Prolong Gold Antifade Reagent before
immunofluorescence microscopy. The panels in the figure are for Nef, p-LIMK1, and merged images. Arrows identify Nef expressing cells. Bar, 5
um. B) The densitometric mean intensity of p-LIMK1 stained cells was quantified from Nef/WT and Nef/G2A transfected cells and compared to
non-Nef expressing cells.
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Page 9 of 14Electrophoretic mobility shift assay did not reveal any
significant loss of RARE or RXRE probe binding activity in
response to F-actin modifying agent (data not shown) sug-
gesting that mechanisms other than the effect on DNA
binding are involved in transcriptional inhibition induced
by F-actin disruption.
CFL1 is a key F-actin remodeling protein that severs
F-actin and thereby allows addition and assembly of new
actin filaments, the so-called actin-treadmilling [15]. Both
siRNA-mediated knockdown and overexpression of CFL1
attenuated retinoid receptor function showing that CFL1
homeostasis plays a critical role in receptor activity. This
was further evident from the data obtained with constitu-
tively active (S3A) and inactive/dominant-negative (S3E)
mutants of CFL1. Whereas the transfection of cells with
CFL1/WT and S3A mutant induced loss of F-actin con-
tent in the cells expressing these proteins, transfection
with S3E mutant increased F-actin content consistent with
the ability of WT and S3A mutant to severe F-actin and
S3E mutant to increase F-actin content. Loss of transcrip-
tional activation by the expression of S3A and S3E
mutants of CFL1, in addition to CFL1/WT, further
emphasizes the importance of actin homeostasis in the
regulation of retinoid receptor-mediated transcription.
Interestingly, CFL1 overexpression has also been
shown to negatively regulate glucocorticoid receptor
function [31] and thrombin-induced NF-kappaB activity
[37] suggesting that CFL1 homeostasis is also essential
for the activities of steroid hormone-mediated nuclear
receptors as well as other transcription factors besides
retinoid receptors reported in this study.
The role of LIMK1 in the regulation of nuclear hormone
receptor-dependent activation is unknown. Here we have
shown that when overexpres s e dL I M K 1f u n c t i o n sa sa
negative regulator of retinoid receptor function. The
expression of an enzymatically inactive D460A mutant of
LIMK1, that also functions as a dominant-negative pro-
tein, also inhibited receptor activity. These data suggest
that physiological levels of LIMK1 are crucial for receptor
f u n c t i o nd u et oi t sa b i l i t yt or e g u l a t eC F L 1a n da c t i n
cytoskeletal homeostasis. Overexpression of LIMK1 and
loss of LIMK1 activity (D460A mutant expression)
increased and decreased F-actin content respectively, and
deregulated actin dynamics and homeostasis so crucial for
retinoid receptor activity.
A number of previous studies have demonstrated that
Nef expression disturbs F-actin cytoskeleton [17-23]. We
confirmed these observations in this study and found
that Nef expression induced loss of the characteristic
actin ring structure. In addition, we report that Nef
inhibited retinoid receptor mediated transcription. The
gene array analysis of Nef-transfected 293 cells identified
inhibition of endogenous expression of a number of
genes that contain retinoid receptor binding sites in their
promoters. IFIT1, CEBPB, and CRABP2 are known reti-
noic acid inducible genes [34-36] whereas RBM8A and
ACOT2 were found to contain DR2 (RARE) and DR1
(RXRE) consensus sequence elements, respectively,
within their promoter regions upstream of the transcrip-
tion start site.
The role of myristoylation in reducing the receptor
function correlated well with the inability of this Nef
mutant to induce loss of F-actin ring structure. The con-
clusion that the Nef-mediated loss of transcriptional acti-
vation is a consequence of disturbance in the actin
dynamics was supported by the observation that the pre-
sence of Nef exhibited a cooperative effect on the loss of
transcription induced by the actin-modifying agents.
These data show that retinoid receptor mediated tran-
scription is tightly controlled by actin cytoskeletal home-
ostasis and any disturbances in F-actin dynamics that
may include changes in F-actin architecture, length, and
content affect receptor-driven transcription.
In order to gain further insight to understand the role
of actin pathways in modulating retinoid receptor-
mediated function, we next studied the mechanism by
which Nef inhibits actin dynamics. We have shown that
cells expressing Nef had higher levels of phospho-CFL1
suggesting a link between Nef mediated phosphorylation
of CFL1 and inhibition of retinoid receptor-mediated
activation. By inhibiting CFL1 activity Nef protein dis-
turbs F-actin homeostasis that is crucial for normal reti-
noid receptor function. Nef induced phosphorylation of
CFL1 has also recently been reported by others [20,38]
indicating that modification of CFL1 activity is an impor-
tant mechanism by which Nef modulates actin-cytoskele-
tal dynamics and cellular functions. The mechanism
underlying the phosphorylation of CFL1 by Nef is not
known. Although phospho-CFL1 appears to colocalize
with Nef (Figure 5), but Nef did not interact with CFL1
in immunoprecipitation experiments (unpublished obser-
vation). Since Nef lacks any kinase activity, phosphoryla-
tion of CFL1 by Nef is probably induced due its
activation and association with other kinases and/or
adapter proteins like VAV. Nef has been reported to
associate with p-21 associated kinases (PAK) 1 and 2 and
induce activation of these serine/threonine kinases
[39-41]. PAKs are effectors of RAC and CDC42 GTPases
that are known for their role in actin dynamics. PAK1 is
an upstream kinase for LIMK1 that binds and activates
LIMK1 by phosphorylating Thr508 within the activation
loop, resulting in a marked increase in its activity to
phosphorylate CFL1 [42]. In fact treatment of Jurkat cells
with PAK inhibitor IPA3 was able to induce retinoid
receptor transcription and reduce p-CFL1 levels (data
n o ts h o w n )i n d i c a t i n gt h a tP A K - m e d i a t e dC F L 1p h o s -
phocycling plays an important role in retinoid receptor
function.
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Page 10 of 14The ability of Nef to inhibit transcription and induce
CFL1 phosphorylation suggested that Nef might function
by activating LIMK1 thereby inducing CFL1 phosphoryla-
tion. Data presented here support this hypothesis and
demonstrated that the expression of myristoylated Nef
induced significant phosphorylation of LIMK1 at Thr508.
How Nef induces phosphorylation of LIMK1 is not known
but Nef-mediated activation of PAK1 that is known to
directly phosphorylate LIMK1 [42] remains a possibility.
We also found that expression of Nef induces the “round-
ing off” phenotype in cells that is indicative of cell cycle
changes seen in mitotic cells [43,44]. This rounding phe-
notype induced by Nef was associated with increased
phospho-CFL1 and phospho-LIMK1 levels (Figures 5 and
6). Although a number of previous studies have shown
that there is a transient net change in the phospho-CFL1
levels and increase in the phospho-LIMK1 levels during
mitosis and cytokinesis [45-48], but our cell cycle studies
did not reveal any significant changes in the number of
cells in mitotic phase in cells transfected with Nef (data
not shown). It is possible that the “rounding off” pheno-
type seen in this study may reflect the morphological
changes in cells due to disturbance in F-actin dynamics
and not the presence of mitotic cells.
Our data strongly indicates that Nef is a modulator of
LIMK1 and CFL1 phosphorylation that modifies the func-
tion of these two proteins and inhibits retinoid receptor
transcription by interfering in actin architecture. This is
further emphasized in our overexpression data using
various CFL1 and LIMK1 mutants that induce loss of
transcription and disturbance in the actin dynamics. Data
obtained with Nef protein not only confirm the role of
actin dynamics in retinoid receptor transcription, but also
provide mechanistic information. Although we cannot rule
out the possibility that HIV-Nef inhibits receptor function
through additional mechanisms besides modifying CFL1
phosphocycling, modification of actin dynamics by Nef
and the crucial role of actin homeostasis in receptor func-
tion provide evidence that Nef inhibits receptor function
largely by inhibiting actin dynamics.
In conclusion, we have described a critical role of actin-
cytoskeleton dynamics in normal retinoid receptor-
mediated function and found that LIMK1-mediated
phosphocycling of CFL1 plays a crucial role in maintain-
ing actin homeostasis and receptor activity. Our studies
however, do not rule out the importance of LIMK2 in
retinoid receptor function. We have identified HIV-1 Nef
protein as an inhibitor of receptor function by virtue of
its LIMK1-meditaed CFL1 modifying activity and used it
as tool to study the importance of actin dynamics in
receptor function. Further studies are needed to identify
the mechanism by which disturbances in actin dynamics
directly alter the ability of retinoid receptors to activate
transcription in the nuclear compartment. A number of
s t u d i e sh a v ed e m o n s t r a t e dt h a tn u c l e a ra c t i ne x i s t si n
dynamic equilibrium between monomeric and polymeric
forms, indicating that polymerization of monomeric
G-actin is an essential feature of actin dynamics in the
nucleoplasm [49,50]. A recent report has shown that
most of the G-actin pool in the nucleus is bound to CFL
suggesting the importance of CFL in the regulation of
nuclear function [51]. LIMK1 [45-48] and CIN are
known to have nuclear functions [47,52].
CFL1 is an essential component of T cell activation pro-
cess and is crucial for IS formation. Most of the CFL1 in
naive T cells is found in the inactive phosphorylated form
that following TCR activation, is dephosphorylated into an
active form [10,12,13]. Our previous studies have revealed
that retinoid receptor function is inhibited during T cell
activation [6,8] suggesting that actin modification may
play a role in such inhibition. Data presented here strongly
suggests that changes in the actin cytoskeletal dynamics
may indeed contribute to the loss of nuclear retinoid
receptor function following T cell activation. Future
studies should reveal the relationship between CFL1-
mediated IS formation and modulation of retinoid recep-
tor function.
Conclusions
We have described a critical role of actin-cytoskeleton
dynamics in retinoid receptor-mediated function and
shown that LIMK1-mediated phosphocycling of CFL1
plays a crucial role in maintaining actin homeostasis and
receptor activity. We have identified HIV-1 Nef protein as
an inhibitor of receptor function by virtue of its LIMK1-
meditaed CFL1 modifying activity and used it as tool to
study the importance of actin dynamics in receptor func-
tion. Our previous studies have revealed that retinoid
receptor function is inhibited during T cell activation sug-
gesting that actin modification may play a role in such
inhibition. Data presented here strongly suggests that
changes in the actin cytoskeletal dynamics may indeed
contribute to the loss of nuclear retinoid receptor function
following T cell activation.
Methods
Cells and reagents
Tl y m p h o c y t el e u k e m i aJ u r k a tc e l ll i n e( c l o n eE 6 - 1 )w a s
maintained in RPMI 1640 medium (Biowhittaker, Freder-
ick, MD) supplemented with 10 mM HEPES buffer,
2 mM L-glutamine, and 1% Penn/Strep, and 10% fetal
bovine serum (Hyclone, Logan, UT). Human peripheral
blood mononuclear cells, obtained by lymphapheresis of
healthy donors, were purified by Ficoll density gradient
centrifugation. Purified peripheral blood mononuclear
cells were treated with phytohemagglutinin and interleu-
kin-2 for 2 days in AIM-V medium (Invitrogen, Carlsbad,
CA) supplemented with 10% fetal bovine serum. The
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Page 11 of 14cells were washed to remove phytohemagglutinin and
maintained in interleukin-2 as described earlier [6]. In
this report, these cells will be referred to as proliferating
peripheral blood T (PBT) cells. PBT cells were 98% CD3-
positive as monitored by flow cytometry. HEK-293 cells
were maintained in DMEM medium containing 10% fetal
bovine serum. Latrunculin A, swinholide, and jasplakino-
l i d ew e r ef r o mE M DB i o s c i e n c e s( G i b b s t o w n ,N J ) .H I V -
Nef antibody was obtained from the NIH AIDS Research
and Reference Reagent Program. Antibodies to CFL1 and
phospho-threonine-508 LIMK1 were purchased from
Santa Cruz Biotechnology, Inc (Santa Cruz, CA). Antibo-
dies to beta-actin and GAPDH were from Abcam (Cam-
bridge, MA). Alexa Fluor 555 Phalloidin, Prolong Gold
Antifade Reagent with DAPI, and antibodies to phospho-
serine-3 CFL1 were obtained from Invitrogen.
Western blot
Protein extracts were electrophoresed in a 10-12%
NuPAGE Bis Tris Gel using NuPAGE MES-SDS running
buffer (Invitrogen, Carlsbad, CA), and transferred to a
PVDF membrane using XCell Blot Module (Invitrogen).
Protein was detected using fluorophore labeled secondary
antibodies (1:7,500) and the Odyssey Infrared Imaging
System (Li-cor Biotechnology, Lincoln, Nebraska).
Plasmids, transfections, and RNA interference (RNAi)
Retinoid receptor mediated activation was studied by tran-
sient transfection using RXRE containing luciferase plas-
mids, CRBPII-TK-Luc or TATA-DR1-Luc and RARE
containing plasmid TKRARE-Luc (also referred to as repor-
ter plasmids in this report) as described [6,8]. CRBPII-TK-
Luc or TATA-DR1-Luc plasmids are specific for RXR:
RXR homodimers and RXR:RAR heterodimers whereas
TKRARE-Luc reporter is specific for RXR:RAR heterodi-
mers. Sp1-Luc reporter vector was from Affymetrix, Inc.
(Santa Clara, CA). Human CFL1 and LIMK-1 cDNA clones
were obtained from the Dana-Farber/Harvard Cancer
Center DNA Resource Core (Boston, MA). The cDNAs
from these plasmids were cloned into pLenti7.3/V5-DEST
Gateway Vector (Invitrogen). CFL1 mutants S3A and S3E
and LIMK-1 mutant D460A were created by mutagenesis.
All mutations were verified by DNA sequencing and
expression confirmed by Western blot analysis. HIV-1 Nef
expressing plasmid p96ZM651nef-opt was obtained from
the NIH AIDS Research and Reference Reagent Program.
Myristoylation (G2A) mutant and a non-expressing control
plasmid (Nef/Stop, containing two stop codons at amino
acid positions 5 and 13) were created using mutagenesis
and verified by sequencing. Flag-tagged Nef/WT and Flag-
tagged Nef/G2A plasmids were constructed using PCR by
introducing 3× Flag sequence at the C-terminal end of the
Nef sequence from Nef/WT and Nef/G2A plasmids. CFL1
expression was knocked down in Jurkat cells by short
interfering RNA (siRNA) purchased from Applied Bio-
systems. Jurkat cells were transfected by electroporation
using a Gene Pulser II (Bio-Rad, CA) at 0.250 kV and 975
uF as described [7]. PBT cells were electroporated using a
T cell Nucleofection kit from Amaxa Biosystems (Cologne,
Germany) according to the manufacturer’s instructions as
described [5]. In some experiments cells were treated with
antibodies to CD3 (5.0 ug/ml), antibodies to CD28 (1.0 ug/
ml), PMA (50 ng/ml), PHA (2.5 ug/ml), and 9-cis retinoic
acid (9-CRA) (1.0 uM) following 16 h of transfection.
Twenty hours after treatment cells were harvested for luci-
ferase measurement. Luciferase activity was normalized to
protein concentrations in the extracts. The values in the fig-
ures represent the mean of three independent experiments
with standard error calculated for each value.
Fluorescence microscopy
Jurkat cells were transfected with plasmids using the
Fugene HD transfection reagent from Roche (Indianapo-
lis, IN). After 36 h cells were washed with PBS and incu-
bated on poly-L-Lysine coated chamber slides for 1 hr.
293 cells were grown in chamber slides, transfected with
plasmids using Fugene-HD, and incubated for 36 h. Cells
were washed with PBS and fixed with 4% formaldehyde
for 30 min and permeabilized with 0.1% Triton X-100 for
10 min. Cells were blocked with 5% BSA/PBS, stained
with primary antibodies for 1-2 h, washed with PBS and
labeled with dye-conjugated secondary antibodies
(1:2,000). F-actin staining was performed using Alexa
Fluor 555 Phalloidin. Cells were mounted in Prolong
Gold Antifade Reagent with DAPI (Invitrogen). Immuno-
fluorescence and laser-based confocal images were
obtained using an Axioimager D1 Zeiss microscope and
an Olympus Fluoview 1000 inverted microscope respec-
tively. The densitometric mean intensity of F-actin stain
was quantified using AxioVision software from Zeiss
Imager D1 fluorescent microscope.
Gene Array and Real-time RT-PCR
293 cells were transfected in three different experiments
(each time in duplicate) with Nef/Stop and Nef/WT plas-
mids for 36 h using Fugene-HD. Total RNA was isolated
using Qiagen (Germantown, MD) RNAeasy kit by follow-
ing manufacture’s protocol. 250 ng total RNA was used
for the Affymetrix whole transcript sense target labeling
assay. The terminal labeled products were fragmented
and analyzed on Affymetrix (Santa Clara, CA) human
Exon 1.0 ST arrays. The data were analyzed with Partek
(St. Louis, Missouri) using the GC content and probe
sequence adjusted RMA normalization. Genes were sum-
marized by Turkey’s biweight method. The significant
genes were selected by P value less than 0.05 and fold
change 1.3. The array data was submitted to GEO reposi-
tory under accession number GSE31665. For Real-Time
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Page 12 of 14RT-PCR total RNA was reverse transcribed with Super-
script II reverse transcriptase (Invitrogen) in the presence
of 2.5 μM random hexamers. The products of reverse
transcription were subject to Real-Time PCR with gene-
specific primers using 7500 Fast Real-Time PCR System
and Fast SYBR Green Master Mix from Applied Biosys-
tems. The comparative threshold cycle method was used
to calculate the relative gene expression.
Statistical analysis
The results obtained from three independent experi-
ments were expressed as mean ± SD. Statistical analysis
was assessed by Student’s t test. A value of p < 0.05 was
considered significant.
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